¡°	aripiprazole carbostyril core	10.210114007726597
	conventional antipsychotic drug	9.515222541463494
	antipsychotic drug discovery	9.514012806539327
	potential antipsychotic activity	9.509746352995117
	antipsychotic research	9.49222052292056
¡°	aripiprazole butoxy linker	9.149609348702405
	atypical antipsychotic drug	8.201932533066687
	seven atypical antipsychotic	8.180822911789173
	chlorpromazine antipsychotic property	7.51504124230286
	first antipsychotic drug	7.133370990122288
	certain carbostyril derivative	6.902484334355801
¡°	generic aripiprazole product	6.881199433263666
	carbostyril compound	6.791322152645981
	first postclozapine atypical antipsychotic	6.650111787879014
	unsubstituted propoxy	6.610132233225511
	Aripiprazole carbostyril ring	5.649062965221864
	7-linked carbostyril derivative	5.57819577372597
	every FDA approve atypical antipsychotic	5.474249167153725
	unsubstituted butoxy compound	5.2807475860265285
	know carbostyril derivative	5.176854082475505
	nine carbostyril derivative test compound	4.2082900343203375
	nine specific carbostyril derivative	4.155703744096974
	carbostyril moiety	4.084397285130371
	2-chloro substitute propoxy	3.857344559624954
	4-chloro substitute propoxy	3.7235634974609995
	ED	3.693593580371104
	two potent carbostyril derivative	3.528109776166571
	prior art carbostyril derivative compound	3.494709845006486
	Mitsukuni Murasaki	2.938799760198156
	mouse jumping datum	2.526998202739168
	5-propoxy linker	2.4923042552725514
	nonstatutory double patenting	2.195512061937355
	risperidone	2.1398215472078586
	SE	2.137123156516074
	unsubstituted phenyl ring	2.06762997432268
	antihistaminic agent	1.9157052434704116
	Compound	1.6958380188031894
	orthostatic hypotension	1.3379801251469225
	antihistaminic effect	1.2473886653898587
	LEXIS	1.2053462192159892
	mouse jumping test datum	1.1289442424240161
	nonstatutory obviousness type double patenting	1.0979863765298163
	hallucination	1.0705870764222623
	delusion	1.0705870764222623
	Clozapine	1.0705870764222623
	depressor	1.0705870764222623
	thirst	1.0705870764222623
	parkinsonism	1.0705870764222623
	kilogram	1.0705870764222623
	4-dihydrocarbostyril dihydrochloride	1.0705870764222623
	frank hypotension	1.070418000819014
	side effect clozapine	1.0697283405810571
	chlorine atom	1.0243028022001626
	lexis	0.9627426964294368
	extrapyramidal symptom	0.8909646005282674
	compound antihistaminic activity	0.8139136899210644
	positive symptom	0.7686186975695357
	terminal phenyl ring	0.706326755883447
	antimanic depressive psychosis agent	0.6917257215490346
	piperazine ring	0.6495620595325998
	bipolar disorder	0.6371141590048094
	autistic disorder	0.6371141590048094
	sedative	0.6175429320139039
	constipation	0.6175429320139039
	antischizophrenia agent	0.5804264910037154
	pediatric exclusivity	0.5393198361476247
	Schizophrenia	0.5354628277664454
	etiology	0.5354628277664454
	cognitive deficit	0.5354628277664454
	poverty	0.5354628277664454
	pleasure	0.5354628277664454
	tardive dyskinesia	0.5354628277664454
	hyperprolactinemia	0.5354628277664454
	Researchers	0.5354628277664454
	agranulocytosis	0.5354628277664454
	olanzapine	0.5354628277664454
	quetiapine	0.5354628277664454
	ziprasidone	0.5354628277664454
	paliperidone	0.5354628277664454
	asenapine	0.5354628277664454
	iloperidone	0.5354628277664454
	tachycordia	0.5354628277664454
	Methamphetamine	0.5354628277664454
	LDOPA	0.5354628277664454
	propoxy,2	0.5354628277664454
	anxiolytic	0.5354628277664454
	tachycardia	0.5354628277664454
	sleeplessness	0.5354628277664454
	fatigability	0.5354628277664454
	pediatric patient	0.47251735273992646
	potential central nervous system	0.4707243636389486
	central nervous control action	0.465919299097426
	irritability	0.4304840129297776
	prolactin elevation	0.4221659722324601
	EPS side effect	0.405396281061272
	conventional central nervous control agent	0.3932252259321204
	New Psycho Neuro Agents	0.3832679984184314
	laundry list	0.3581742118635131
	positive negative symptom	0.3358416803883067
	dopamine receptor	0.33260487747093487
	ethoxy substituent	0.3309129297321597
	depression	0.32622706967801135
	antianxiety drug	0.3140484948295618
	presurgery drug	0.3140484948295618
	antipyretic agent	0.31286436667580697
	analgetic agent	0.31286436667580697
	accident	0.3088691166984748
	stagger	0.3088691166984748
	diminished propensity	0.28144398148830674
	approximately nine trillion compound	0.28118203254669444
	delay dyscinesia	0.27769924384056527
	delay dyschezia	0.27769924384056527
	sudden decrease	0.2764691449066338
	disturbed concentration	0.27595713238053976
	mouse jump study	0.27468167824724393
	Chemical Name	0.27431100712806955
	heavy headedness	0.27210166107291783
	three methylene unit	0.2699001748877937
	four methylene -CH2- unit	0.2692312536012902
	culmination	0.2677314138832227
	quinolinone fuse ring	0.2420436821227968
	anti psychotic drug	0.24174792954199847
	anti psychotic action	0.22322125265749287
	speech	0.21531007794522306
	second potent derivative	0.21111116764175053
	Swedish Patent Publication	0.19774129312254274
	5-milligram dose	0.1962619576608469
	Longi	0.19457765053344123
	extra pyramidal disturbance	0.18207574388080472
	sleep induce agent	0.18161604977686469
	jump behavior	0.1744967360502315
	debilitate mental disease	0.16669976120191835
	antihistamine	0.16316512040058542
	dozen	0.16316512040058542
	antagonism	0.1544345583492374
	attractive lead compound	0.1433264048041162
	muscle relaxant	0.13932406094831468
	New Antipsychotic Drug	0.1392569790177388
	analgesic	0.12974692717542435
	central muscle relax agent	0.12325176273046015
	obviousness obviousness type double patenting.1	0.1200279829820957
	great potency	0.11555966579363039
	Amended Order	0.11345997695944941
	two hydrogen atom	0.10658749258888256
	fever lower agent	0.10332197087099505
	Amended Memorandum Opinion	0.09925790164311449
	result double bond	0.09429083578391222
	good compound	0.08701617632354391
	Phase Study	0.0864979514605327
	ninety six different compound	0.08564637851994232
	one hydrogen atom	0.07994059548377759
	gold standard	0.07721965832635545
	billion dollar	0.0765666221035423
	treatment resistant treatment intolerant patient	0.07585385776971687
	Barr Pharmaceuticals	0.07410147983843296
	Barr Laboratories	0.06605309249544901
	final purported lead compound	0.0637866334027198
	Ex Parte Reexamination Certificate	0.06214341894297279
	two carbon atom	0.06199728129176494
	totally compound	0.0612474468035377
	Golden Blount	0.06081215574441405
	Example	0.057759761818419866
	rigorous blood testing	0.05454789817848151
	second alleged lead compound	0.05354260568930236
	conventional drug	0.05240898352427895
	two prior art reference compound	0.05216998559388086
	conventional agent	0.05122485537052408
	weakness	0.05095860223134937
	inability	0.04529118858560439
	D.N.J. November	0.04470710035797762
	efficacy	0.041823370551124804
	life threaten decrease	0.038759953787420295
	patentee prior art development compound	0.03873599803692429
	closing argument	0.03816749538577733
	drug development effort	0.0375511449167377
	generic drug manufacturer	0.035177545001951985
	pre operative drug	0.03060581747660259
	annual sale	0.030147168272821472
	human population	0.028615212809342688
	Final Judgment	0.02848755514765249
	problematic side effect	0.026999901160195853
	white blood cell	0.026955222240995915
	single bond	0.024841315526451482
	chemical name	0.023808981637657115
	researcher effort	0.023151404780118682
	clinical trial	0.02285806878165158
	i4i Ltd.	0.022686905647768218
	advantageous effect	0.022358674466745512
	following chemical structure	0.021962450382945153
	J.A.	0.021527964106828307
	toxicity side effect	0.02131031266964665
	daily routine work	0.020751670981906847
	extensive research	0.020499794972991203
	drawback	0.02025394776778403
	motivation	0.020132861231653906
	New Jersey	0.019971448085915916
	subsequent research	0.019706370947581067
	general chemical formula	0.018976300351126747
	regulate action	0.016986459900499913
	skilled artisan	0.016786095479719768
	active ingredient	0.01656101102264517
	scientist	0.016451436994634156
	two prior art foreign counterpart	0.016427079637313397
	reasonable expectation	0.015837964325888142
	foreign priority date	0.015095420646937212
	several decade	0.014949433520936327
	blood pressure	0.014897930487340965
	Food Drug Administration	0.012412197742300207
	Br	0.011074427927098632
	serious potential side effect	0.009433658779738358
	prior art foreign application	0.009142341741983823
	pharmaceutical composition	0.008953135375074705
	structural difference	0.008466029985240087
	Abbreviated New Drug Application	0.008425721499107487
	flat affect	0.0072419699282411775
	Lourie	0.0067924124433975195
	follow table	0.006423020769559556
	activate action	0.006218712992845546
	prior art declaration	0.0061773475671154585
	mechanism	0.005668342700202852
	approval	0.005668342700202852
	latter category	0.005519394791155769
	effective dosage	0.005462663464550817
	five year term extension	0.004864876236916933
	author	0.004717707308671001
	one percent	0.004097838541331686
	relationship	0.0039355591682770944
	ANDA filing	0.0038568864794825846
	conflict evidence	0.003195340272783808
	definite firm conviction	0.002887330410765524
	sole exception	0.002784446418986142
	suitable amount	0.0027258241561447538
	six month period	0.002468125189771798
	low value	0.002467465888100746
	commercial success	0.002444450375035293
	August	0.002286718578886967
	desire	0.002217686580193969
	class	0.002130219833515123
	add treatment	0.0019931951778057377
	defense	0.001969023440085645
	improvement	0.001898226388635176
	contrast	0.0018907073922642215
	December	0.0017828167221755494
	bench trial	0.0016347826687158936
	alleged infringer	0.0015995108254197312
	Obviousness	0.0014706653613326913
	April	0.001391883310615205
	co inventor	0.0013690017549457887
	numerous example	0.0012722914017938502
	October	0.0012107328702294468
	pertinent art	0.0011588041417792488
	individual	0.0011437208831707702
	March	0.0010870809911083452
	literal infringement	0.0009993939212786997
	long feel need	0.0009784299864878084
	prior art article	0.0008154829130827521
	first two measure	0.000813733754540227
	asserted prior art	0.0007872973545771771
	content	0.0005982760232620254
	prior art publication	0.0005842078037646307
	January	0.000571273816920479
	several company	0.00047879764779851057
	clear convincing evidence	0.00040477666111146703
	commercial manufacture	0.0002886939636226275
	objective evidence	0.00026546978311305384
	underlie finding	0.00018927790752203122
	lack	0.0001404296042647101
	underlie factual finding	0.00013087373985661485
	ordinary skill	0.00010859955798072594
	validity	9.690553719303725e-05
	respect	5.9845980944315624e-05
	three set	5.419320412980063e-05
	background	5.137703874656669e-05
	analysis	5.086080545964892e-05
	final decision	4.448053664126347e-05
	method	3.820446207855522e-05
	Claim	3.27597096210064e-05
	holding	2.6405967139186633e-05
	particular emphasis	2.251451317418882e-05
	level	2.2408969566502086e-05
	jurisdiction	2.1789105491215634e-05
	law de novo	1.799743509703378e-05
	clear error	1.6181538334746297e-05
	favor	1.458960420416975e-05
	mean	7.64550357710366e-06
	Idaho	4.797571994463606e-06
	support evidence	2.761053223716741e-06
	assert prior art	2.1712846175200912e-06
	subject matter	1.8256316582870737e-06
	scope	7.660165965434816e-07
	district court conclusion	7.298283049897225e-07
	present invention	3.1521269335945326e-07
	present appeal	3.119979627789706e-07
	party	6.160308096021067e-08
	issue	1.9379727293022802e-09
	District	0.0
	Court	0.0
	Appeals	0.0
	Inc.	0.0
	Fed	0.0
